Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Web tool helps gauge risk of having genetic mutation linked to colon cancer

27.09.2006
Researchers hopeful that tool's ease of use will lead to early screening for those with elevated risk

Researchers at Brigham and Women's Hospital and Dana-Faber Cancer Institute have developed an online questionnaire to help physicians determine whether patients at risk for colon cancer are likely to carry mutations in two genes linked to the most common hereditary form of the disease.

The investigators, who report their results in the Sept. 27 issue of the Journal of the American Medical Association, developed the questionnaire based on findings from a five-year study of clinical and genetic data from nearly 2,000 patients. They determined that personal and family medical histories reliably predict an individual's chances of harboring mutations in the cancer-related genes.

The questionnaire, available at http://www.dfci.org/premm and developed from the largest study of these gene mutations in U.S. patients, is one of the first tools with which doctors can quantify patients' likelihood of carrying inherited mutations associated with colon cancer. "We hope the model, and the ease of accessing it on the Web, will lead to healthcare providers being easily able to identify at-risk patients and result in screening at an early age," says Sapna Syngal, MD, MPH, of Brigham and Women's and the study's senior author. "Prevention remains one of our best weapons against colon and other cancers."

The study's lead author is Judith Balmana, MD, formerly of Dana-Farber and currently at the Hospital Vall D'Hebron, Universitat Autonoma of Barcelona, Spain.

Between two and five percent of all colorectal cancers in western countries arise in people with mutations in the genes MLH1 and MSH2 -- a condition called Lynch syndrome. "Our goal was to produce a model that could help doctors quantify a patient's risk of having MLH1 and MSH2 mutations," says Syngal. "Patients at high risk would then be referred for tissue or genetic testing to ascertain whether or not they carry the mutations."

In families with Lynch syndrome (also called hereditary nonpolyposis colorectal cancer, or HNPCC), individuals have an increased risk of developing colorectal cancer, often at an early age. Family members also face a higher-than-average risk for other cancers, including those of the uterine tract lining, ovaries, stomach, small intestines, urinary tract, brain, and skin.

Early identification of people with MLH1 and MSH2 mutations is important because such individuals require a different level of medical management, Syngal notes. Guidelines call for them to receive a colonoscopy every year or two, compared to every ten years for the general population, and they're screened at a more frequent rate for other tumors as well. For some individuals, prophylactic surgeries such as removal of the colon and/or uterus and ovaries may be recommended.

For the current study, Myriad Genetic Laboratories, Inc., of Salt Lake City, provided Syngal and her colleagues with genetic test results from blood samples of 898 patients at risk for colon cancer, along with information on the medical history of the patients and their families. All potentially identifying information had been removed from the data to protect patient anonymity. Investigators matched the samples that tested positive for MLH1 and MSH2 mutations with patients' reports of their medical history. (The reports came from healthcare providers, not patients.)

"We found a close correlation between patients and their families' history of colon and other HNPCC-related cancers and the presence of the two gene mutations," says Syngal, who is also an assistant professor of medicine at Harvard Medical School. After researchers developed the questionnaire model, they validated it with data from an additional 1,016 patients.

Kevin Myron | EurekAlert!
Further information:
http://www.dfci.harvard.edu/
http://www.danafarber.org

More articles from Health and Medicine:

nachricht Speed data for the brain’s navigation system
06.12.2016 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Speed data for the brain’s navigation system

06.12.2016 | Health and Medicine

What happens in the cell nucleus after fertilization

06.12.2016 | Life Sciences

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>